Literature DB >> 29782853

Cholesterol promotes the migration and invasion of renal carcinoma cells by regulating the KLF5/miR-27a/FBXW7 pathway.

Zheng Liu1, Xiaowen Liu2, Shuai Liu1, Qingwei Cao3.   

Abstract

Clear cell renal cell carcinoma (ccRCC) is the most common and lethal subtype of renal cell carcinoma. Accumulation of cholesterol and cholesterol ester is a remarkable feature of ccRCC. However, the effect of cholesterol on ccRCC remains unknown. Out results showed that cholesterol treatment significantly promoted cells migration and invasion in ccRCC. Mechanism analysis indicated that cholesterol induced KLF5 expression. KLF5 positively regulated the transcription of miR-27a, increasing miR-27a expression. MiR-27a directly targeted FBXW7 by binding to its 3'UTR, reducing FBXW7 expression. FBXW7 silencing further increased the expression of KLF5 and miR-27a, and promoted cells migration and invasion. These results suggested that cholesterol accelerated ccRCC cells migration and invasion by regulating KLF5/miR-27a/FBXW7 axis.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Keywords:  Cholesterol; Clear cell renal cell carcinoma; FBXW7; KLF5; miR-27a

Mesh:

Substances:

Year:  2018        PMID: 29782853     DOI: 10.1016/j.bbrc.2018.05.122

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  18 in total

Review 1.  Krüppel-like factor (KLF)5: An emerging foe of cardiovascular health.

Authors:  Dimitra Palioura; Antigone Lazou; Konstantinos Drosatos
Journal:  J Mol Cell Cardiol       Date:  2021-10-13       Impact factor: 5.000

Review 2.  Recent Insight on Regulations of FBXW7 and Its Role in Immunotherapy.

Authors:  Liangliang Xing; Leidi Xu; Yong Zhang; Yinggang Che; Min Wang; Yongxiang Shao; Dan Qiu; Honglian Yu; Feng Zhao; Jian Zhang
Journal:  Front Oncol       Date:  2022-06-24       Impact factor: 5.738

3.  Surface cholesterol-enriched domains specifically promote invasion of breast cancer cell lines by controlling invadopodia and extracellular matrix degradation.

Authors:  Mauriane Maja; Danahe Mohammed; Andra C Dumitru; Sandrine Verstraeten; Maxime Lingurski; Marie-Paule Mingeot-Leclercq; David Alsteens; Donatienne Tyteca
Journal:  Cell Mol Life Sci       Date:  2022-07-12       Impact factor: 9.207

Review 4.  Cholesterol Metabolic Reprogramming in Cancer and Its Pharmacological Modulation as Therapeutic Strategy.

Authors:  Isabella Giacomini; Federico Gianfanti; Maria Andrea Desbats; Genny Orso; Massimiliano Berretta; Tommaso Prayer-Galetti; Eugenio Ragazzi; Veronica Cocetta
Journal:  Front Oncol       Date:  2021-05-24       Impact factor: 6.244

Review 5.  MicroRNA-27a (miR-27a) in Solid Tumors: A Review Based on Mechanisms and Clinical Observations.

Authors:  Jingcheng Zhang; Zhe Cao; Gang Yang; Lei You; Taiping Zhang; Yupei Zhao
Journal:  Front Oncol       Date:  2019-09-12       Impact factor: 6.244

6.  Metformin exhibited anticancer activity by lowering cellular cholesterol content in breast cancer cells.

Authors:  Ankit Sharma; Shreetama Bandyopadhayaya; Kaushik Chowdhury; Tanu Sharma; Rekha Maheshwari; Amlan Das; Gopal Chakrabarti; Vipin Kumar; Chandi C Mandal
Journal:  PLoS One       Date:  2019-01-09       Impact factor: 3.240

7.  N6-Isopentenyladenosine Inhibits Colorectal Cancer and Improves Sensitivity to 5-Fluorouracil-Targeting FBXW7 Tumor Suppressor.

Authors:  Donatella Fiore; Chiara Piscopo; Maria Chiara Proto; Michele Vasaturo; Fabrizio Dal Piaz; Bruno Marcello Fusco; Cristina Pagano; Chiara Laezza; Maurizio Bifulco; Patrizia Gazzerro
Journal:  Cancers (Basel)       Date:  2019-09-28       Impact factor: 6.639

Review 8.  Impact of cholesterol-pathways on breast cancer development, a metabolic landscape.

Authors:  Alina González-Ortiz; Octavio Galindo-Hernández; Gerson N Hernández-Acevedo; Gustavo Hurtado-Ureta; Victor García-González
Journal:  J Cancer       Date:  2021-05-19       Impact factor: 4.207

Review 9.  The crosstalk: exosomes and lipid metabolism.

Authors:  Wei Wang; Neng Zhu; Tao Yan; Ya-Ning Shi; Jing Chen; Chan-Juan Zhang; Xue-Jiao Xie; Duan-Fang Liao; Li Qin
Journal:  Cell Commun Signal       Date:  2020-08-03       Impact factor: 5.712

10.  Baseline Serum Cholesterol Levels Predict the Response of Patients with Advanced Non-Small Cell Lung Cancer to Immune Checkpoint Inhibitor-Based Treatment.

Authors:  Jingtao Tong; Yifei Mao; Ziru Yang; Quan Xu; Zhen Zheng; Hui Zhang; Jingjing Wang; Sandian Zhang; Weibo Rong; Lu Zheng
Journal:  Cancer Manag Res       Date:  2021-05-18       Impact factor: 3.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.